LAWRENCE, Mass., April 22, 2015 /PRNewswire/ -- NxStage® Kidney Care, Inc. (NxKC), a subsidiary of NxStage® Medical, Inc. (Nasdaq: NXTM), today announced the opening of its North Orlando, Florida dialysis center. The new clinic is owned and operated in partnership with Central Florida Kidney Centers, a nonprofit dialysis provider serving central Florida for over 42 years. Conveniently located in Casselberry, the center boasts a team of highly-trained medical personnel dedicated to providing high-quality, personalized and compassionate care to dialysis patients and their loved ones.
"We are committed to expanding patient and nephrologist access to home dialysis therapy options that have been shown to improve patient quality of life, sense of well-being and independence," said Dr. Alexander Markovich, Medical Director at NxKC North Orlando. "Our goal is to deliver outstanding care, and we work with our patients to provide them a secure and effective dialysis experience."
All NxKC centers feature comprehensive home dialysis training tailored to the individual needs of each patient. Facilities also offer customized therapy options using the NxStage System One™, including home hemodialysis (HHD), home nocturnal hemodialysis, flexible in-center hemodialysis, and short-term respite care. Additionally, the center offers peritoneal dialysis (PD) and transplant assistance, and is furnished with modern, comfortable amenities, offering patients a quiet and relaxed therapy environment.
As part of the NxStage Kidney Care RV Tour, which includes stops at all NxKC centers in Florida, the North Orlando facility will host an Open House on Monday, May 18th from 11 AM - 6:30 PM. All interested patients and their families are invited to attend and learn more about the flexible therapy options and services offered. The center is located at 174 State Road 436, Unit D102, Casselberry, FL. More information can be found at www.nxstagekidneycare.com/locations/northorlando and www.nxstagekidneycare.com/rv-tour.
About NxStage Kidney Care
NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients. For more information, please visit www.nxstagekidneycare.com or call (866) 694-2707.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen K. Sheppard, Esq.
Tel: (978) 332-5923
SOURCE NxStage Kidney Care, Inc.